HCV Infection in the Republic of Sakha (Yakutia) and Its Role of Genotypes in Clinical Outcomes of the Disease

Aim of the research. To study the epidemic manifestations of HCV infection in the Republic of Sakha (Yakutia) in order to develop recommendations for improving the effectiveness and quality of treatment and prevention measures.
Materials and methods. The paper uses materials from the official statistics of the Territorial Department of Rospotrebnadzor of the Republic of Sakha (Yakutia) for 1994–2018, and data from the electronic register «Chronic viral hepatitis in the RS (Ya)» (2019). Molecular and biological studies of the genotype of the hepatitis C virus were performed jointly on the basis of the Federal state budgetary Institution «Central research Institute of epidemiology» of Rospotrebnadzor (2007–2011, n = 75). To assess the epidemiological situation, the rate of increase in morbidity is calculated on the basis of data equalized by the method of least squares. Statistical processing was performed using the SPSS 17 program. The critical significance level is assumed to be 0.05.
Results. Thus, the study of long-term dynamics of the incidence of viral hepatitis shows that in the Republic of Sakha (Yakutia) a consistently high level of incidence of HCV with adverse trends in the development of the epidemic process remains. Analysis of the distribution of different variants of HCV genotypes allowed us to establish the prevalence of genotype 1b, which can determine the high frequency of cirrhosis and primary liver cancer. The current situation in the Republic regarding the incidence of viral hepatitis requires detailed monitoring, improvement of epidemiological surveillance and introduction of modern treatment methods. It is also necessary to improve the quality of health education among the population of the Republic.

1. Yushchuk ND, Znoiko OO, Dudina KR, Bely PA. The problem of viral hepatitis C in the Russian Federation. Therapeutic archive. 2014; 86(10): 77-81. (In Russ.)

2. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Scientific World Journal. 2012; 2012: 719494. doi: 10.1100/2012/719494

3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-2917. doi: 10.1002/ijc.25516

4. Chulanov VP, Pimenov NN, Mamonova NA, Sagalova OI, Shestakova IV, Pokrovsky VI. Chronic hepatitis C as a health problem in Russia today and tomorrow. Therapeutic archive. 2015; 87(11): 5-6. doi: 10.17116/terarkh201587115-10 (In Russ.)

5. Pimenov NN, Chulanov VP, Komarova SV, Karandashova IV, Neverov AD, Mikhailovskaya GV, et al. Hepatitis C in Russia: epidemiological characteristics and ways to improve diagnostics and surveillance. Epidemiology and Infectious Diseases. 2012; (3): 4-10. (In Russ.)

6. Sleptsova SS. Parenteral viral hepatitis and their outcomes in the Republic of Sakha (Yakutia). Moscow: Chekhovskiy Pechatnyy Dvor; 2017. (In Russ.)

7. Yushchuk ND, Klimova EA, Znoyko OO, Karetkina GN, et al. Viral hepatitis: clinic, diagnosis, treatment. Moscow: GEOTAR-Media; 2015. (In Russ.)

8. Savilov ED, Malov SI, Malov IV, Gantulga D, Miroshnichenko IA, Erdenebayar N, et al. Epidemiological manifestations of viral hepatitis C in representatives of the Caucasian and Mongoloid races. Journal of Microbiology, Epidemiology and Immunobiology. 2016; (1): 9-16. doi: 10.36233/0372-9311-2016-1-9-17 (In Russ.)

9. Savilov ED, Malov SI, Malov IV, Ogarkov OB, Astafiev VA, Chemezova NN, et al. Chronic hepatitis C in the Siberian Federal district: incidence analysis and genotype evolution of the pathogen. Epidemiology and Vaccinal Prevention. 2018; 17(101): 56-62. doi: 10.31631/2073-3046-2018-17-4-56-62 (In Russ.)

10. Nechaev VV, Mukomolov SL, Nazarov VYu, Pozhidaeva LN, Chakharyan VV. Chronic viral hepatitis: past, present, future. Epidemiology and Infectious Diseases. 2013; (3): 4-9. (In Russ.)

11. Soboleva NV, Karlsen AA, Kozhanova TV, Kichatova VS, Klushkina VV, Isaeva OV, et al. The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation. Journal Infectology. 2017; 9(2): 56-64. doi: 10.22625/2072-6732-2017-9-2-56-64 (In Russ.)